Bharat Biotech to Ramp up Covaxin Production by 200 Million

HYDERABAD: Bharat Biotech on Thursday announced the quick ramp up of additional manufacturing capacities for Covid-19 vaccine Covaxin by an additional 200 million. The manufacturing capacities for India's first indigenous Covid vaccine have been ramped up at Chiron Behring Vaccines, a wholly-owned subsidiary of Bharat Biotech at Ankleshwar, Gujarat. (IANS)

Also Read :Disheartening to hear states complaining: Bharat Biotech